Finance

Lists
D01:FRA
Belite Bio Inc
€137.00
-4.20%
(-6.00) 1D
Aug 14, 6:00:02 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for D01...
Open
€144.00
High
€144.00
Low
€137.00
Mkt. cap
6.39B
Avg. vol.
2.00
Volume
0.00
52-wk high
€164.00
52-wk low
€51.00
No. of employees
41
Open
€144.00
High
€144.00
Low
€137.00
Mkt. cap
6.39B
Avg. vol.
2.00
Volume
0.00
52-wk high
€164.00
52-wk low
€51.00
No. of employees
41
News stories
From web sources and news partners
About Belite Bio Inc
CEO-
Employees41
Founded2016
Headquarters-
SectorPharmaceutical industry
Websitebelitebio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.05M
10.31M
14.62M
15.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.55M
12.71M
13.45M
17.02M
Operating expense
17.60M
23.02M
28.08M
32.68M
Total operating expenses
17.60M
23.02M
28.08M
32.68M
Operating income
-17.60M
-23.02M
-28.08M
-32.68M
Other non operating income
1.28M
-2.14M
-417.00K
5.75M
EBT including unusual items
-16.32M
-21.69M
-25.32M
-26.94M
EBT excluding unusual items
-16.32M
-21.69M
-25.32M
-26.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.32M
-21.69M
-25.32M
-26.94M
Net profit margin
-
-
-
-
Earnings per share
-0.50
-0.65
-0.70
-0.68
Interest and investment income
-
3.47M
3.17M
-
Interest expense
-
-
-2.00K
-
Net interest expenses
-
3.47M
3.17M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.55M
-22.97M
-28.03M
-32.64M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps